Thrivent Financial For Lutherans Agios Pharmaceuticals, Inc. Transaction History
Thrivent Financial For Lutherans
- $51.6 Billion
- Q4 2024
A detailed history of Thrivent Financial For Lutherans transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 17,526 shares of AGIO stock, worth $542,079. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,526
Previous 24,603
28.76%
Holding current value
$542,079
Previous $1.09 Million
47.3%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding AGIO
# of Institutions
244Shares Held
59.9MCall Options Held
270KPut Options Held
332K-
Farallon Capital Management LLC San Francisco, CA5.67MShares$176 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$174 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$150 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$109 Million2.3% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.42MShares$75 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.7B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...